Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin therapy for squint.

J Lee1, J Elston, S Vickers

  • 1Botulinum Toxin Clinic, Moorfields Eye Hospital, London.

Eye (London, England)
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of neuromuscular exercises to promote movement quality and reduce musculoskeletal injury during initial military training in Royal Navy recruits.

BMJ military health·2024
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UK.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Assessment of the Implementation of Lung Cancer Consensus Statements From the Royal College of Radiologists in 2021; Progress and Barriers.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Implementing Genomic Testing for Lung Cancer Into Routine Clinical Practice - The Welsh Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022
Same journal

Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.

Eye (London, England)·2026
Same journal

Oculomics and the NHS: A UK opportunity to translate eye-derived biomarkers into population health.

Eye (London, England)·2026
Same journal

Long-term follow-up and outcomes of a Diabetic Eye Screening Programme in patients aged 80 with no diabetic eye disease at baseline: should we be routinely screening this cohort?

Eye (London, England)·2026
Same journal

Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes.

Eye (London, England)·2026
Same journal

"When the lens drew a continent: a cartographic clue to Alport syndrome".

Eye (London, England)·2026
Same journal

Infographic: efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity.

Eye (London, England)·2026
See all related articles

Botulinum neurotoxin A injections were given to over 400 patients with extraocular muscle issues. This study reviews the reasons for treatment and the results achieved at Moorfields Eye Hospital.

Area of Science:

  • Ophthalmology
  • Neurology

Background:

  • Botulinum neurotoxin A is used to treat various medical conditions.
  • Extraocular muscle disorders can significantly impact patient quality of life.

Purpose of the Study:

  • To describe the indications for Botulinum neurotoxin A therapy.
  • To discuss the outcomes of Botulinum neurotoxin A injections in patients with extraocular muscle conditions.

Main Methods:

  • Retrospective analysis of patient data.
  • Review of treatment indications and therapeutic outcomes.
  • Data collected from the Botulinum Toxin Clinic at Moorfields Eye Hospital (November 1982-present).

Main Results:

  • Four hundred and five patients received Botulinum neurotoxin A injections.

Related Experiment Videos

  • Analysis of indications for treatment provided insights into clinical practice.
  • Outcomes of the therapy were documented and evaluated.

    • Conclusions:

    • Botulinum neurotoxin A is a viable treatment option for extraocular muscle disorders.
    • The study provides valuable data on the long-term use and efficacy of Botulinum neurotoxin A in ophthalmology.